Takeo Yoshihara (T Yoshihara)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Combination Therapy

Mesenchymal Stem Cells

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Journal of gastroenterology and hepatology

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani, Tsunaki Sawada, Naoki Shibuya, Yuka Fukuo, Hiroki Kiyohara, Hiromu Morikubo, Keiichi Tominaga, Kazuki Kakimoto, Takayuki Imai, Katsuki Yaguchi, Shojiro Yamamoto, Katsuyoshi Ando, Nobuaki Nishimata, Takeo Yoshihara, Akira Andoh, Toshifumi Hibi, Katsuyoshi Matsuoka, null null
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing. Alimentary pharmacology & therapeutics 60 (1) (2024)
Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani, Tsunaki Sawada, Naoki Shibuya, Yuka Fukuo, Hiroki Kiyohara, Hiromu Morikubo, Keiichi Tominaga, Kazuki Kakimoto, Takayuki Imai, Katsuki Yaguchi, Shojiro Yamamoto, Katsuyoshi Ando, Nobuaki Nishimata, Takeo Yoshihara, Akira Andoh, Toshifumi Hibi, Katsuyoshi Matsuoka, null null
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing. Alimentary pharmacology & therapeutics (2024)
Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani, Tsunaki Sawada, Naoki Shibuya, Yuka Fukuo, Hiroki Kiyohara, Hiromu Morikubo, Keiichi Tominaga, Kazuki Kakimoto, Takayuki Imai, Katsuki Yaguchi, Shojiro Yamamoto, Katsuyoshi Ando, Nobuaki Nishimata, Takeo Yoshihara, Akira Andoh, Toshifumi Hibi, Katsuyoshi Matsuoka, null null
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing. Alimentary pharmacology & therapeutics 60 (1) (2024)
Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani, Tsunaki Sawada, Naoki Shibuya, Yuka Fukuo, Hiroki Kiyohara, Hiromu Morikubo, Keiichi Tominaga, Kazuki Kakimoto, Takayuki Imai, Katsuki Yaguchi, Shojiro Yamamoto, Katsuyoshi Ando, Nobuaki Nishimata, Takeo Yoshihara, Akira Andoh, Toshifumi Hibi, Katsuyoshi Matsuoka, null null
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing. Alimentary pharmacology & therapeutics 60 (1) (2024)
Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani, Tsunaki Sawada, Naoki Shibuya, Yuka Fukuo, Hiroki Kiyohara, Hiromu Morikubo, Keiichi Tominaga, Kazuki Kakimoto, Takayuki Imai, Katsuki Yaguchi, Shojiro Yamamoto, Katsuyoshi Ando, Nobuaki Nishimata, Takeo Yoshihara, Akira Andoh, Toshifumi Hibi, Katsuyoshi Matsuoka, null null
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing. Alimentary pharmacology & therapeutics 60 (1) (2024)
Takeo Yoshihara, Shinichiro Shinzaki, H Iijima, Y Tsujii, Yoshito Hayashi, Tetsuo Takehara
Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: Concerns about the different results observed between two meta-analyses. Journal of gastroenterology and hepatology (2023)
Takeo Yoshihara, Shinichiro Shinzaki, H Iijima, Y Tsujii, Yoshito Hayashi, Tetsuo Takehara
Combination therapy of ustekinumab and immunomodulator for inflammatory bowel disease: concerns about the different results observed between two meta-analyses. Journal of gastroenterology and hepatology (2023)
Yuriko Otake-Kasamoto, Kiyoshi Takeda, Toshihiro Kishikawa, Shinichiro Shinzaki, Taku Tashiro, Takahiro Amano, Mizuki Tani, Takeo Yoshihara, Bo Li, Haruka Tani, Li Liu, Akio Hayashi, Daisuke Okuzaki, Daisuke Motooka, Shota Nakamura, Yukinori Okada, Hideki Iijima, Kiyoshi Takeda, Tetsuo Takehara
Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response. The Journal of experimental medicine 219 (7) (2022)